Valeant Pharmaceuticals International (VRX) · page 46 of 47
The slide details specific financial ratios (90% conversion, 4x leverage target, 5.75% cost of debt) and compares them to current/transaction-specific metrics.
Conference presentation · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 4/4
list 2/2 title 2/2
Components 4
bullet bullet headline headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.